COMMUNIQUÉS West-GlobeNewswire

Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025)
18/07/2025
Patient insights informed the development of pilavapadin, Lexicon’s investigational, novel, non-opioid treatment for people suffering from DPNP THE WOODLANDS, Texas, July 18, 2025 (GLOBE NEWSWIRE) -- Lexicon [...]
Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development
18/07/2025
Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development Atif Abbas, MD joins as CMO, bringing over 25 years’ [...]
EURneffy® approved as the first needle-free anaphylaxis treatment of adults and children in the UK
18/07/2025
Inside Information ALK ( ALKB:DC / OMX: ALK B ) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EUR neffy ® 2 mg in the United Kingdom (UK) for anaphylaxis treatment of [...]
Generation Bio Announces 1-for-10 Reverse Stock Split
18/07/2025
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced [...]
Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors
18/07/2025
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene [...]
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
18/07/2025
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
18/07/2025
EUR neffy ( neffy ® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children ( > 30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to market EUR [...]
Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast
18/07/2025
Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025. New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- In the ever- [...]
Hapbee Reports First-Ever Quarterly Profit in Q2 2025 and Achieves Third Consecutive Quarter of Growth
18/07/2025
Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), a [...]
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
18/07/2025
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD, Conn., July 18, [...]
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
18/07/2025
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD, Conn., July 18, [...]
Disclosure of notification received from Alychlo
18/07/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 18 July 2025 – 6 PM CET Disclosure of notification received from Alychlo Fagron received a notification based on the Belgian law of 2 May 2007 [...]
Anosh Inc Foundation Announces Illinois-Based Super PAC to Support Community-Focused Policy Priorities
18/07/2025
New initiative aims to promote reforms in public safety, tax policy, and fiscal transparency through nonpartisan civic engagement Dr. Anosh Ahmed Image CHICAGO, July 18, 2025 (GLOBE NEWSWIRE) -- The Anosh Inc Foundation [...]
Anosh Inc Foundation Establishes Super PAC to Promote Legislative Priorities Across Illinois
18/07/2025
New Super PAC will advocate for property tax reform, public safety, and fiscal responsibility to improve quality of life for Illinois communities Dr. Anosh Ahmed Image CHICAGO, July 18, 2025 (GLOBE NEWSWIRE) -- The [...]
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
18/07/2025
Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, July 18, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a [...]
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
18/07/2025
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has [...]
Human Appeal USA Mobilizes Relief and Volunteer Event for Texas Flood Victims
18/07/2025
Dallas-based nonprofit leads volunteer health kit packing event and launches nationwide donation drive to support families affected by Texas floods DALLAS, July 18, 2025 (GLOBE NEWSWIRE) -- In the wake of devastating [...]
Orion Group Half-Year Financial Report January–June 2025
18/07/2025
ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2025 18 JULY 2025 at 12:00 EEST Orion Group Half-Year Financial Report January–June 2025 April–June 2025 Highlights Net sales totalled EUR 416.5 (April–June 2024: 328.2) [...]
ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia
18/07/2025
ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal [...]

Pages